Publications by authors named "Henna-Riikka Junlen"
Page 1 of 1
Synopsis of recent research by authors named "Henna-Riikka Junlen"
- Henna-Riikka Junlen’s research primarily focuses on improving treatment outcomes and understanding the biology of various forms of lymphoma, including splenic marginal zone lymphoma and chronic lymphocytic leukemia, with significant studies conducted from 2000 to 2023 in Sweden.
- Recent findings indicate that the use of rituximab has improved survival rates in elderly patients with splenic marginal zone lymphoma, and that absolute B cell counts in blood can predict long-term responses to rituximab monotherapy in follicular lymphoma patients.
- Additionally, Junlen has explored the impact of cannabinoids on lymphoma treatment, revealing potential benefits from a single dose of THC/CBD in chronic lymphocytic leukemia patients, while also assessing chemotactic responses of lymphoma cells to various biological agents like 2-arachidonoylglycerol.